<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34726731</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-9538</ISSN><JournalIssue CitedMedium="Internet"><Volume>218</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>The Journal of experimental medicine</Title><ISOAbbreviation>J Exp Med</ISOAbbreviation></Journal><ArticleTitle>Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with enterovirus rhombencephalitis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e20211349</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1084/jem.20211349</ELocationID><Abstract><AbstractText>Enterovirus (EV) infection rarely results in life-threatening infection of the central nervous system. We report two unrelated children with EV30 and EV71 rhombencephalitis. One patient carries compound heterozygous TLR3 variants (loss-of-function F322fs2* and hypomorphic D280N), and the other is homozygous for an IFIH1 variant (loss-of-function c.1641+1G&gt;C). Their fibroblasts respond poorly to extracellular (TLR3) or intracellular (MDA5) poly(I:C) stimulation. The baseline (TLR3) and EV-responsive (MDA5) levels of IFN-β in the patients' fibroblasts are low. EV growth is enhanced at early and late time points of infection in TLR3- and MDA5-deficient fibroblasts, respectively. Treatment with exogenous IFN-α2b before infection renders both cell lines resistant to EV30 and EV71, whereas post-infection treatment with IFN-α2b rescues viral susceptibility fully only in MDA5-deficient fibroblasts. Finally, the poly(I:C) and viral phenotypes of fibroblasts are rescued by the expression of WT TLR3 or MDA5. Human TLR3 and MDA5 are critical for cell-intrinsic immunity to EV, via the control of baseline and virus-induced type I IFN production, respectively.</AbstractText><CopyrightInformation>© 2021 Chen et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5354-4170</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Shanghai Sixth Hospital, Shanghai Jiaotong University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Huie</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6283-3452</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin-Nalda</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3590-0186</Identifier><AffiliationInfo><Affiliation>Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastard</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5926-8437</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivière</LastName><ForeName>Jacques G</ForeName><Initials>JG</Initials><Identifier Source="ORCID">0000-0003-1055-2063</Identifier><AffiliationInfo><Affiliation>Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-6473-348X</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colobran</LastName><ForeName>Roger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5964-536X</Identifier><AffiliationInfo><Affiliation>Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Diagnostic Immunology Group, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Division, Genetics Department, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Danyel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3124-0245</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tung</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4577-3926</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manry</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5998-2051</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasek</LastName><ForeName>Mary</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8902-6431</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boucherit</LastName><ForeName>Soraya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-8819-7594</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo</LastName><ForeName>Lazaro</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6648-8684</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rozenberg</LastName><ForeName>Flore</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7212-2021</Identifier><AffiliationInfo><Affiliation>Laboratory of Virology, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubart</LastName><ForeName>Mélodie</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4383-7930</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Neurology Department, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Abel</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7016-6493</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Helen C</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-5582-9110</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Immunology and Microbiology, Intramural Research Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Soler Palacin</LastName><ForeName>Pere</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0346-5570</Identifier><AffiliationInfo><Affiliation>Infection in Immunocompromised Pediatric Patients Research Group, Vall d'Hebron Research Institute, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron University Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Casanova</LastName><ForeName>Jean-Laurent</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-7782-4169</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Shen-Ying</ForeName><Initials>SY</Initials><Identifier Source="ORCID">0000-0002-9449-3672</Identifier><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale U1163, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Paris, Imagine Institute, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI088364</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1TR001866</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Exp Med</MedlineTA><NlmUniqueID>2985109R</NlmUniqueID><ISSNLinking>0022-1007</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077190">Interferon alpha-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000614170">Interferon-alpha2b</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C452815">IFIH1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical><Chemical><RegistryNumber>O84C90HH2L</RegistryNumber><NameOfSubstance UI="D011070">Poly I-C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077190" MajorTopicYN="N">Interferon alpha-2</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073658" MajorTopicYN="N">Loss of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008661" MajorTopicYN="N">Metabolism, Inborn Errors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011070" MajorTopicYN="N">Poly I-C</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012249" MajorTopicYN="N">Rhombencephalon</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Disclosures: The authors declare no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34726731</ArticleId><ArticleId IdType="pmc">PMC8570298</ArticleId><ArticleId IdType="doi">10.1084/jem.20211349</ArticleId><ArticleId IdType="pii">212742</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abe, Y., Fujii K., Nagata N., Takeuchi O., Akira S., Oshiumi H., Matsumoto M., Seya T., and Koike S.. 2012. The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J. Virol. 86:185–194. 10.1128/JVI.05245-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05245-11</ArticleId><ArticleId IdType="pmc">PMC3255933</ArticleId><ArticleId IdType="pubmed">22072781</ArticleId></ArticleIdList></Reference><Reference><Citation>Abston, E.D., Coronado M.J., Bucek A., Bedja D., Shin J., Kim J.B., Kim E., Gabrielson K.L., Georgakopoulos D., Mitzner W., and Fairweather D.. 2012. Th2 regulation of viral myocarditis in mice: different roles for TLR3 versus TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012:129486. 10.1155/2012/129486</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/129486</ArticleId><ArticleId IdType="pmc">PMC3195533</ArticleId><ArticleId IdType="pubmed">22013485</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug, M.J., Cloud G., Bradley J., Sánchez P.J., Romero J., Powell D., Lepow M., Mani C., Capparelli E.V., Blount S., et al. . National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group . 2003. Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis. Pediatr. Infect. Dis. J. 22:335–341. 10.1097/01.inf.0000059765.92623.70</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.inf.0000059765.92623.70</ArticleId><ArticleId IdType="pubmed">12690273</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulou, L., Holt A.C., Medzhitov R., and Flavell R.A.. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732–738. 10.1038/35099560</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35099560</ArticleId><ArticleId IdType="pubmed">11607032</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen, L.L., Mørk N., Reinert L.S., Kofod-Olsen E., Narita R., Jørgensen S.E., Skipper K.A., Höning K., Gad H.H., Østergaard L., et al. . 2015. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J. Exp. Med. 212:1371–1379. 10.1084/jem.20142274</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20142274</ArticleId><ArticleId IdType="pmc">PMC4548062</ArticleId><ArticleId IdType="pubmed">26216125</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrés, C., Vila J., Gimferrer L., Piñana M., Esperalba J., Codina M.G., Barnés M., Martín M.C., Fuentes F., Rubio S., et al. . 2019. Surveillance of enteroviruses from paediatric patients attended at a tertiary hospital in Catalonia from 2014 to 2017. J. Clin. Virol. 110:29–35. 10.1016/j.jcv.2018.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.11.004</ArticleId><ArticleId IdType="pmc">PMC7172671</ArticleId><ArticleId IdType="pubmed">30530096</ArticleId></ArticleIdList></Reference><Reference><Citation>Antona, D., Kossorotoff M., Schuffenecker I., Mirand A., Leruez-Ville M., Bassi C., Aubart M., Moulin F., Lévy-Bruhl D., Henquell C., et al. . 2016. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro Surveill. 21:30402. 10.2807/1560-7917.ES.2016.21.46.30402</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.46.30402</ArticleId><ArticleId IdType="pmc">PMC5144948</ArticleId><ArticleId IdType="pubmed">27918268</ArticleId></ArticleIdList></Reference><Reference><Citation>Asgari, S., Schlapbach L.J., Anchisi S., Hammer C., Bartha I., Junier T., Mottet-Osman G., Posfay-Barbe K.M., Longchamp D., Stocker M., et al. . 2017. Severe viral respiratory infections in children with IFIH1 loss-of-function mutations. Proc. Natl. Acad. Sci. USA. 114:8342–8347. 10.1073/pnas.1704259114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704259114</ArticleId><ArticleId IdType="pmc">PMC5547624</ArticleId><ArticleId IdType="pubmed">28716935</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubart, M., Gitiaux C., Roux C.J., Levy R., Schuffenecker I., Mirand A., Bach N., Moulin F., Bergounioux J., Leruez-Ville M., et al. . 2020. Severe Acute Flaccid Myelitis Associated With Enterovirus in Children: Two Phenotypes for Two Evolution Profiles? Front. Neurol. 11:343. 10.3389/fneur.2020.00343</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00343</ArticleId><ArticleId IdType="pmc">PMC7198806</ArticleId><ArticleId IdType="pubmed">32411086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.H., Zhang Y., Dorgham K., Philippot Q., Rosain J., Béziat V., et al. . COVID Human Genetic Effort . 2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 370:eabd4585. 10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P., Manry J., Chen J., Rosain J., Seeleuthner Y., AbuZaitun O., Lorenzo L., Khan T., Hasek M., Hernandez N., et al. . 2021. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency. J. Clin. Invest. 131:e139980. 10.1172/JCI139980</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI139980</ArticleId><ArticleId IdType="pmc">PMC7773360</ArticleId><ArticleId IdType="pubmed">32960813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bearden, D., Collett M., Quan P.L., Costa-Carvalho B.T., and Sullivan K.E.. 2016. Enteroviruses in X-Linked Agammaglobulinemia: Update on Epidemiology and Therapy. J. Allergy Clin. Immunol. Pract. 4:1059–1065. 10.1016/j.jaip.2015.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2015.12.015</ArticleId><ArticleId IdType="pubmed">26883540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bsibsi, M., Ravid R., Gveric D., and van Noort J.M.. 2002. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61:1013–1021. 10.1093/jnen/61.11.1013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.11.1013</ArticleId><ArticleId IdType="pubmed">12430718</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrerizo, M., Echevarria J.E., González I., de Miguel T., and Trallero G.. 2008. Molecular epidemiological study of HEV-B enteroviruses involved in the increase in meningitis cases occurred in Spain during 2006. J. Med. Virol. 80:1018–1024. 10.1002/jmv.21197</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21197</ArticleId><ArticleId IdType="pubmed">18428125</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova, J.L., and Abel L.. 2020. The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? Hum. Genet. 139:681–694. 10.1007/s00439-020-02184-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-020-02184-w</ArticleId><ArticleId IdType="pmc">PMC7251220</ArticleId><ArticleId IdType="pubmed">32462426</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova, J.L., and Abel L.. 2021. Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories. Annu. Rev. Pathol. 16:23–50. 10.1146/annurev-pathol-031920-101429</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-031920-101429</ArticleId><ArticleId IdType="pmc">PMC7923385</ArticleId><ArticleId IdType="pubmed">32289233</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova, J.L., Conley M.E., Seligman S.J., Abel L., and Notarangelo L.D.. 2014. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J. Exp. Med. 211:2137–2149. 10.1084/jem.20140520</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140520</ArticleId><ArticleId IdType="pmc">PMC4203950</ArticleId><ArticleId IdType="pubmed">25311508</ArticleId></ArticleIdList></Reference><Reference><Citation>Casrouge, A., Zhang S.Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., Alcais A., Picard C., Mahfoufi N., Nicolas N., et al. . 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 314:308–312. 10.1126/science.1128346</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1128346</ArticleId><ArticleId IdType="pubmed">16973841</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan, L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., et al. . Outbreak Study Group . 2000. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. Clin. Infect. Dis. 31:678–683. 10.1086/314032</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, L.Y., Lin H.Y., Gau S.S., Lu C.Y., Hsia S.H., Huang Y.C., Huang L.M., and Lin T.Y.. 2019. Enterovirus A71 neurologic complications and long-term sequelae. J. Biomed. Sci. 26:57. 10.1186/s12929-019-0552-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pmc">PMC6688366</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan, V.S., Furr S.R., Sterka D.G. Jr., Nelson D.A., Moerdyk-Schauwecker M., Marriott I., and Grdzelishvili V.Z.. 2010. Vesicular stomatitis virus infects resident cells of the central nervous system and induces replication-dependent inflammatory responses. Virology. 400:187–196. 10.1016/j.virol.2010.01.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.01.025</ArticleId><ArticleId IdType="pubmed">20172575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C.S., Yao Y.C., Lin S.C., Lee Y.P., Wang Y.F., Wang J.R., Liu C.C., Lei H.Y., and Yu C.K.. 2007. Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J. Virol. 81:8996–9003. 10.1128/JVI.00236-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, B.S., Lee H.C., Lee K.M., Gong Y.N., and Shih S.R.. 2020. Enterovirus and Encephalitis. Front. Microbiol. 11:261. 10.3389/fmicb.2020.00261</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.00261</ArticleId><ArticleId IdType="pmc">PMC7044131</ArticleId><ArticleId IdType="pubmed">32153545</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe, J., Kelker M.S., and Wilson I.A.. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science. 309:581–585. 10.1126/science.1115253</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1115253</ArticleId><ArticleId IdType="pubmed">15961631</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciancanelli, M.J., Huang S.X., Luthra P., Garner H., Itan Y., Volpi S., Lafaille F.G., Trouillet C., Schmolke M., Albrecht R.A., et al. . 2015. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science. 348:448–453. 10.1126/science.aaa1578</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa1578</ArticleId><ArticleId IdType="pmc">PMC4431581</ArticleId><ArticleId IdType="pubmed">25814066</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalwai, A., Ahmad S., Pacsa A., and Al-Nakib W.. 2009. Echovirus type 9 is an important cause of viral encephalitis among infants and young children in Kuwait. J. Clin. Virol. 44:48–51. 10.1016/j.jcv.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2008.10.007</ArticleId><ArticleId IdType="pubmed">19081296</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom, S.C., Rossen J.W., van Furth A.M., and Obihara C.C.. 2016. Enterovirus and parechovirus infection in children: a brief overview. Eur. J. Pediatr. 175:1023–1029. 10.1007/s00431-016-2725-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-016-2725-7</ArticleId><ArticleId IdType="pmc">PMC4930465</ArticleId><ArticleId IdType="pubmed">27156106</ArticleId></ArticleIdList></Reference><Reference><Citation>Dropulic, L.K., and Cohen J.I.. 2011. Severe viral infections and primary immunodeficiencies. Clin. Infect. Dis. 53:897–909. 10.1093/cid/cir610</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir610</ArticleId><ArticleId IdType="pmc">PMC3189169</ArticleId><ArticleId IdType="pubmed">21960712</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, D.M., Dunn G., Minor P.D., Schild G.C., Cann A.J., Stanway G., Almond J.W., Currey K., and Maizel J.V. Jr. 1985. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 314:548–550. 10.1038/314548a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/314548a0</ArticleId><ArticleId IdType="pubmed">2986004</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowlkes, A.L., Honarmand S., Glaser C., Yagi S., Schnurr D., Oberste M.S., Anderson L., Pallansch M.A., and Khetsuriani N.. 2008. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J. Infect. Dis. 198:1685–1691. 10.1086/592988</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/592988</ArticleId><ArticleId IdType="pubmed">18959496</ArticleId></ArticleIdList></Reference><Reference><Citation>Frothingham, T.E. 1958. ECHO virus type 9 associated with three cases simulating meningococcemia. N. Engl. J. Med. 259:484–485. 10.1056/NEJM195809042591007</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM195809042591007</ArticleId><ArticleId IdType="pubmed">13578088</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii, K., Sudaka Y., Takashino A., Kobayashi K., Kataoka C., Suzuki T., Iwata-Yoshikawa N., Kotani O., Ami Y., Shimizu H., et al. . 2018. VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection. J. Virol. 92:e00682-18. 10.1128/JVI.00682-18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00682-18</ArticleId><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, D., Ciancanelli M.J., Zhang P., Harschnitz O., Bondet V., Hasek M., Chen J., Mu X., Itan Y., Cobat A., et al. . 2021. TLR3 controls constitutive IFN-β antiviral immunity in human fibroblasts and cortical neurons. J. Clin. Invest. 131:e134529. 10.1172/JCI134529</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI134529</ArticleId><ArticleId IdType="pmc">PMC7773389</ArticleId><ArticleId IdType="pubmed">33393505</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin, L., Barchet W., Gilfillan S., Cella M., Beutler B., Flavell R.A., Diamond M.S., and Colonna M.. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA. 103:8459–8464. 10.1073/pnas.0603082103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603082103</ArticleId><ArticleId IdType="pmc">PMC1464000</ArticleId><ArticleId IdType="pubmed">16714379</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier, M., Alexander L., and Wimmer E.. 1996. Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc. Natl. Acad. Sci. USA. 93:2370–2375. 10.1073/pnas.93.6.2370</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.6.2370</ArticleId><ArticleId IdType="pmc">PMC39803</ArticleId><ArticleId IdType="pubmed">8637880</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y., Audry M., Ciancanelli M., Alsina L., Azevedo J., Herman M., Anguiano E., Sancho-Shimizu V., Lorenzo L., Pauwels E., et al. . 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208:2083–2098. 10.1084/jem.20101568</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20101568</ArticleId><ArticleId IdType="pmc">PMC3182056</ArticleId><ArticleId IdType="pubmed">21911422</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardarson, H.S., Baker J.S., Yang Z., Purevjav E., Huang C.H., Alexopoulou L., Li N., Flavell R.A., Bowles N.E., and Vallejo J.G.. 2007. Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 292:H251–H258. 10.1152/ajpheart.00398.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00398.2006</ArticleId><ArticleId IdType="pubmed">16936008</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman, M., Ciancanelli M., Ou Y.H., Lorenzo L., Klaudel-Dreszler M., Pauwels E., Sancho-Shimizu V., Pérez de Diego R., Abhyankar A., Israelsson E., et al. . 2012. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209:1567–1582. 10.1084/jem.20111316</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111316</ArticleId><ArticleId IdType="pmc">PMC3428952</ArticleId><ArticleId IdType="pubmed">22851595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez, N., Bucciol G., Moens L., Le Pen J., Shahrooei M., Goudouris E., Shirkani A., Changi-Ashtiani M., Rokni-Zadeh H., Sayar E.H., et al. . 2019. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines. J. Exp. Med. 216:2057–2070. 10.1084/jem.20182295</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20182295</ArticleId><ArticleId IdType="pmc">PMC6719432</ArticleId><ArticleId IdType="pubmed">31270247</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C.C., Liu C.C., Chang Y.C., Chen C.Y., Wang S.T., and Yeh T.F.. 1999. Neurologic complications in children with enterovirus 71 infection. N. Engl. J. Med. 341:936–942. 10.1056/NEJM199909233411302</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, H.I., Lin J.Y., and Chen S.H.. 2019. EV71 Infection Induces IFNβ Expression in Neural Cells. Viruses. 11:1121. 10.3390/v11121121</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121121</ArticleId><ArticleId IdType="pmc">PMC6950376</ArticleId><ArticleId IdType="pubmed">31817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Itan, Y., Shang L., Boisson B., Patin E., Bolze A., Moncada-Vélez M., Scott E., Ciancanelli M.J., Lafaille F.G., Markle J.G., et al. . 2015. The human gene damage index as a gene-level approach to prioritizing exome variants. Proc. Natl. Acad. Sci. USA. 112:13615–13620. 10.1073/pnas.1518646112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1518646112</ArticleId><ArticleId IdType="pmc">PMC4640721</ArticleId><ArticleId IdType="pubmed">26483451</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones, T.P.W., Buckland M., Breuer J., and Lowe D.M.. 2019. Viral infection in primary antibody deficiency syndromes. Rev. Med. Virol. 29:e2049. 10.1002/rmv.2049</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2049</ArticleId><ArticleId IdType="pubmed">31016825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouanguy, E., Béziat V., Mogensen T.H., Casanova J.L., Tangye S.G., and Zhang S.Y.. 2020. Human inborn errors of immunity to herpes viruses. Curr. Opin. Immunol. 62:106–122. 10.1016/j.coi.2020.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2020.01.004</ArticleId><ArticleId IdType="pmc">PMC7083196</ArticleId><ArticleId IdType="pubmed">32014647</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubelt, B., and Lipton H.L.. 2014. Enterovirus/picornavirus infections. Handb. Clin. Neurol. 123:379–416. 10.1016/B978-0-444-53488-0.00018-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-444-53488-0.00018-3</ArticleId><ArticleId IdType="pubmed">25015496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., and Fisher P.B.. 2002. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. USA. 99:637–642. 10.1073/pnas.022637199</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.022637199</ArticleId><ArticleId IdType="pmc">PMC117358</ArticleId><ArticleId IdType="pubmed">11805321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato, H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., Uematsu S., Jung A., Kawai T., Ishii K.J., et al. . 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature. 441:101–105. 10.1038/nature04734</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04734</ArticleId><ArticleId IdType="pubmed">16625202</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan, J., Selvarajoo K., Tsuchiya M., Lee G., and Choi S.. 2007. Toll-like receptor signal transduction. Exp. Mol. Med. 39:421–438. 10.1038/emm.2007.47</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2007.47</ArticleId><ArticleId IdType="pubmed">17934330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, A., Shukla D., Kumar R., Idris M.Z., Misra U.K., and Dhole T.N.. 2011. An epidemic of encephalitis associated with human enterovirus B in Uttar Pradesh, India, 2008. J. Clin. Virol. 51:142–145. 10.1016/j.jcv.2011.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.02.011</ArticleId><ArticleId IdType="pubmed">21444241</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafaille, F.G., Harschnitz O., Lee Y.S., Zhang P., Hasek M.L., Kerner G., Itan Y., Ewaleifoh O., Rapaport F., Carlile T.M., et al. . 2019. Human SNORA31 variations impair cortical neuron-intrinsic immunity to HSV-1 and underlie herpes simplex encephalitis. Nat. Med. 25:1873–1884. 10.1038/s41591-019-0672-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0672-3</ArticleId><ArticleId IdType="pmc">PMC7376819</ArticleId><ArticleId IdType="pubmed">31806906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamborn, I.T., Jing H., Zhang Y., Drutman S.B., Abbott J.K., Munir S., Bade S., Murdock H.M., Santos C.P., Brock L.G., et al. . 2017. Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. J. Exp. Med. 214:1949–1972. 10.1084/jem.20161759</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20161759</ArticleId><ArticleId IdType="pmc">PMC5502429</ArticleId><ArticleId IdType="pubmed">28606988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennette, E.H., Magoffin R.L., Schmidt N.J., and Hollister A.C. Jr. 1959. Viral disease of the central nervous system; influence of poliomyelitis vaccination on etiology. J. Am. Med. Assoc. 171:1456–1464. 10.1001/jama.1959.03010290014006</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1959.03010290014006</ArticleId><ArticleId IdType="pubmed">14415713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lévêque, N., Jacques J., Renois F., Antona D., Abely M., Chomel J.J., and Andréoletti L.. 2010. Phylogenetic analysis of Echovirus 30 isolated during the 2005 outbreak in France reveals existence of multiple lineages and suggests frequent recombination events. J. Clin. Virol. 48:137–141. 10.1016/j.jcv.2010.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2010.03.011</ArticleId><ArticleId IdType="pubmed">20381415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewthwaite, P., Perera D., Ooi M.H., Last A., Kumar R., Desai A., Begum A., Ravi V., Shankar M.V., Tio P.H., et al. . 2010. Enterovirus 75 encephalitis in children, southern India. Emerg. Infect. Dis. 16:1780–1782. 10.3201/eid1611.100672</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1611.100672</ArticleId><ArticleId IdType="pmc">PMC3294525</ArticleId><ArticleId IdType="pubmed">21029544</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, X., Lu C., Stewart M., Xu H., Strong R.K., Igumenova T., and Li P.. 2009. Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5. Arch. Biochem. Biophys. 488:23–33. 10.1016/j.abb.2009.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2009.06.008</ArticleId><ArticleId IdType="pubmed">19531363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, H.K., Seppänen M., Hautala T., Ciancanelli M.J., Itan Y., Lafaille F.G., Dell W., Lorenzo L., Byun M., Pauwels E., et al. . 2014. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology. 83:1888–1897. 10.1212/WNL.0000000000000999</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000999</ArticleId><ArticleId IdType="pmc">PMC4248460</ArticleId><ArticleId IdType="pubmed">25339207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim, H.K., Huang S.X.L., Chen J., Kerner G., Gilliaux O., Bastard P., Dobbs K., Hernandez N., Goudin N., Hasek M.L., et al. . 2019. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J. Exp. Med. 216:2038–2056. 10.1084/jem.20181621</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20181621</ArticleId><ArticleId IdType="pmc">PMC6719423</ArticleId><ArticleId IdType="pubmed">31217193</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, T.Y., Chang L.Y., Hsia S.H., Huang Y.C., Chiu C.H., Hsueh C., Shih S.R., Liu C.C., and Wu M.H.. 2002. The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin. Infect. Dis. 34(Suppl 2):S52–S57. 10.1086/338819</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/338819</ArticleId><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, T.Y., Twu S.J., Ho M.S., Chang L.Y., and Lee C.Y.. 2003. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg. Infect. Dis. 9:291–293. 10.3201/eid0903.020285</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0903.020285</ArticleId><ArticleId IdType="pmc">PMC2963902</ArticleId><ArticleId IdType="pubmed">12643822</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister, R.M., Hummeler K., and Coriell L.L.. 1959. Acute Cerebellar Ataxia. N. Engl. J. Med. 261:1159–1162. 10.1056/NEJM195912032612304</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM195912032612304</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney, S.A., Vermi W., Lonardi S., Rossini C., Otero K., Calderon B., Gilfillan S., Diamond M.S., Unanue E.R., and Colonna M.. 2011. RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice. J. Clin. Invest. 121:1497–1507. 10.1172/JCI44005</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44005</ArticleId><ArticleId IdType="pmc">PMC3069767</ArticleId><ArticleId IdType="pubmed">21403398</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn, P., Stratov I., Nagarajan L., and Davis S.. 2001. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin. Infect. Dis. 32:236–242. 10.1086/318454</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehndiratta, M.M., Mehndiratta P., and Pande R.. 2014. Poliomyelitis: historical facts, epidemiology, and current challenges in eradication. Neurohospitalist. 4:223–229. 10.1177/1941874414533352</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1941874414533352</ArticleId><ArticleId IdType="pmc">PMC4212416</ArticleId><ArticleId IdType="pubmed">25360208</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer, A., van der Sanden S., Snijders B.E., Jaramillo-Gutierrez G., Bont L., van der Ent C.K., Overduin P., Jenny S.L., Jusic E., van der Avoort H.G., et al. . 2012. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology. 423:49–57. 10.1016/j.virol.2011.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.11.021</ArticleId><ArticleId IdType="pubmed">22177700</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyts, I., and Casanova J.L.. 2021. Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway. Eur. J. Immunol. 51:1039–1061. 10.1002/eji.202048793</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202048793</ArticleId><ArticleId IdType="pmc">PMC8900014</ArticleId><ArticleId IdType="pubmed">33729549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami, T., Miyashita H., Takatsuka S., Kuroki Y., and Matsushima N.. 2012. Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains. Gene. 503:235–243. 10.1016/j.gene.2012.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2012.04.007</ArticleId><ArticleId IdType="pubmed">22587897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirand, A., Schuffenecker I., Henquell C., Billaud G., Jugie G., Falcon D., Mahul A., Archimbaud C., Terletskaia-Ladwig E., Diedrich S., et al. . 2010. Phylogenetic evidence for a recent spread of two populations of human enterovirus 71 in European countries. J. Gen. Virol. 91:2263–2277. 10.1099/vir.0.021741-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.021741-0</ArticleId><ArticleId IdType="pubmed">20505012</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore, M. 1982. Centers for Disease Control. Enteroviral disease in the United States, 1970-1979. J. Infect. Dis. 146:103–108. 10.1093/infdis/146.1.103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/146.1.103</ArticleId><ArticleId IdType="pubmed">6282988</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi, H., Osawa T., Ogami K., Ouyang X., Sakaguchi S., Koshiba R., Yanai H., Seko Y., Shitara H., Bishop K., et al. . 2008. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc. Natl. Acad. Sci. USA. 105:20446–20451. 10.1073/pnas.0810372105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810372105</ArticleId><ArticleId IdType="pmc">PMC2629334</ArticleId><ArticleId IdType="pubmed">19074283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunjimi, B., Zhang S.Y., Sørensen K.B., Skipper K.A., Carter-Timofte M., Kerner G., Luecke S., Prabakaran T., Cai Y., Meester J., et al. . 2017. Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J. Clin. Invest. 127:3543–3556. 10.1172/JCI92280</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI92280</ArticleId><ArticleId IdType="pmc">PMC5669568</ArticleId><ArticleId IdType="pubmed">28783042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong, K.C., Badmanathan M., Devi S., Leong K.L., Cardosa M.J., and Wong K.T.. 2008. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J. Neuropathol. Exp. Neurol. 67:532–542. 10.1097/NEN.0b013e31817713e7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31817713e7</ArticleId><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltier, D.C., Simms A., Farmer J.R., and Miller D.J.. 2010. Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling. J. Immunol. 184:7010–7021. 10.4049/jimmunol.0904133</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0904133</ArticleId><ArticleId IdType="pmc">PMC2887731</ArticleId><ArticleId IdType="pubmed">20483728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pérez de Diego, R., Sancho-Shimizu V., Lorenzo L., Puel A., Plancoulaine S., Picard C., Herman M., Cardon A., Durandy A., Bustamante J., et al. . 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 33:400–411. 10.1016/j.immuni.2010.08.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.08.014</ArticleId><ArticleId IdType="pmc">PMC2946444</ArticleId><ArticleId IdType="pubmed">20832341</ArticleId></ArticleIdList></Reference><Reference><Citation>Reikine, S., Nguyen J.B., and Modis Y.. 2014. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Front. Immunol. 5:342. 10.3389/fimmu.2014.00342</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00342</ArticleId><ArticleId IdType="pmc">PMC4107945</ArticleId><ArticleId IdType="pubmed">25101084</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer, M.J., Lavallée D.J., Shanina I., and Horwitz M.S.. 2009. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS One. 4:e4127. 10.1371/journal.pone.0004127</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004127</ArticleId><ArticleId IdType="pmc">PMC2606033</ArticleId><ArticleId IdType="pubmed">19122812</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph, H., Prieto Dernbach R., Walka M., Rey-Hinterkopf P., Melichar V., Muschiol E., Schweitzer-Krantz S., Richter J.W., Weiss C., Böttcher S., et al. . 2017. Comparison of clinical and laboratory characteristics during two major paediatric meningitis outbreaks of echovirus 30 and other non-polio enteroviruses in Germany in 2008 and 2013. Eur. J. Clin. Microbiol. Infect. Dis. 36:1651–1660. 10.1007/s10096-017-2979-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-017-2979-7</ArticleId><ArticleId IdType="pubmed">28409290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho-Shimizu, V., Pérez de Diego R., Lorenzo L., Halwani R., Alangari A., Israelsson E., Fabrega S., Cardon A., Maluenda J., Tatematsu M., et al. . 2011. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Invest. 121:4889–4902. 10.1172/JCI59259</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59259</ArticleId><ArticleId IdType="pmc">PMC3226004</ArticleId><ArticleId IdType="pubmed">22105173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih, S.R., Ho M.S., Lin K.H., Wu S.L., Chen Y.T., Wu C.N., Lin T.Y., Chang L.Y., Tsao K.C., Ning H.C., et al. . 2000. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res. 68:127–136. 10.1016/S0168-1702(00)00162-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(00)00162-3</ArticleId><ArticleId IdType="pubmed">10958984</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade, C.A., McLean C., Scerri T., Giang T.B., Megaloudis S., Strathmore A., Tempany J.C., Nicholls K., D’Arcy C., Bahlo M., et al. . 2019. Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2. J. Clin. Immunol. 39:324–335. 10.1007/s10875-019-00602-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-019-00602-x</ArticleId><ArticleId IdType="pubmed">30927119</ArticleId></ArticleIdList></Reference><Reference><Citation>Slater, L., Bartlett N.W., Haas J.J., Zhu J., Message S.D., Walton R.P., Sykes A., Dahdaleh S., Clarke D.L., Belvisi M.G., et al. . 2010. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 6:e1001178. 10.1371/journal.ppat.1001178</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001178</ArticleId><ArticleId IdType="pmc">PMC2973831</ArticleId><ArticleId IdType="pubmed">21079690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Y., and Leaman D.W.. 2004. Ectopic expression of toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J. Interferon Cytokine Res. 24:350–361. 10.1089/107999004323142213</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999004323142213</ArticleId><ArticleId IdType="pubmed">15212709</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, Y.W., Cleavinger P.J., Li H., Mitchell P.S., Smith T.F., and Persing D.H.. 2000. Analysis of candidate-host immunogenetic determinants in herpes simplex virus-associated Mollaret’s meningitis. Clin. Infect. Dis. 30:176–178. 10.1086/313616</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313616</ArticleId><ArticleId IdType="pubmed">10619748</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoa, P.K., Chiang P.S., Khanh T.H., Luo S.T., Dan T.N., Wang Y.F., Thuong T.C., Chung W.Y., Hung N.T., Wang J.R., et al. . 2013. Genetic and antigenic characterization of enterovirus 71 in Ho Chi Minh City, Vietnam, 2011. PLoS One. 8:e69895. 10.1371/journal.pone.0069895</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069895</ArticleId><ArticleId IdType="pmc">PMC3726754</ArticleId><ArticleId IdType="pubmed">23922846</ArticleId></ArticleIdList></Reference><Reference><Citation>Trallero, G., Avellon A., Otero A., De Miguel T., Pérez C., Rabella N., Rubio G., Echevarria J.E., and Cabrerizo M.. 2010. Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. J. Clin. Virol. 47:170–176. 10.1016/j.jcv.2009.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2009.11.013</ArticleId><ArticleId IdType="pubmed">20007023</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden, L., Wolthers K.C., and van Kuppeveld F.J.. 2015. Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses. 7:4529–4562. 10.3390/v7082832</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7082832</ArticleId><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., Zhao Y., McHenry C.L., Burgens R.V., Miller D.J., et al. . 2009. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J. Immunol. 183:6989–6997. 10.4049/jimmunol.0901386</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901386</ArticleId><ArticleId IdType="pmc">PMC2920602</ArticleId><ArticleId IdType="pubmed">19890046</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelstein, J.A., Marino M.C., Lederman H.M., Jones S.M., Sullivan K., Burks A.W., Conley M.E., Cunningham-Rundles C., and Ochs H.D.. 2006. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore). 85:193–202. 10.1097/01.md.0000229482.27398.ad</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000229482.27398.ad</ArticleId><ArticleId IdType="pubmed">16862044</ArticleId></ArticleIdList></Reference><Reference><Citation>Wörner, N., Rodrigo-García R., Antón A., Castellarnau E., Delgado I., Vazquez È., González S., Mayol L., Méndez M., Solé E., et al. . 2021. Enterovirus-A71 Rhombencephalitis Outbreak in Catalonia: Characteristics, Management and Outcome. Pediatr. Infect. Dis. J. 40:628–633. 10.1097/INF.0000000000003114</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003114</ArticleId><ArticleId IdType="pmc">PMC8189429</ArticleId><ArticleId IdType="pubmed">34097655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, B., and Hur S.. 2015. How RIG-I like receptors activate MAVS. Curr. Opin. Virol. 12:91–98. 10.1016/j.coviro.2015.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2015.04.004</ArticleId><ArticleId IdType="pmc">PMC4470786</ArticleId><ArticleId IdType="pubmed">25942693</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., and Ho M.S.. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 20:895–904. 10.1016/S0264-410X(01)00385-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(01)00385-1</ArticleId><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Yeo A., Phoon M.C., Tan E.L., Poh C.L., Quak S.H., and Chow V.T.. 2010. The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int. J. Infect. Dis. 14:e1076–e1081. 10.1016/j.ijid.2010.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2010.07.006</ArticleId><ArticleId IdType="pubmed">20952237</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang, Z., Gonzalez R., Wang Z., Ren L., Xiao Y., Li J., Li Y., Vernet G., Paranhos-Baccalà G., Jin Q., and Wang J.. 2012. Coxsackievirus A21, enterovirus 68, and acute respiratory tract infection, China. Emerg. Infect. Dis. 18:821–824. 10.3201/eid1805.111376</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1805.111376</ArticleId><ArticleId IdType="pmc">PMC3358056</ArticleId><ArticleId IdType="pubmed">22516379</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, W.X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., and Nomoto A.. 1997. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology. 229:421–428. 10.1006/viro.1997.8450</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.1997.8450</ArticleId><ArticleId IdType="pubmed">9126254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi, E.J., Shin Y.J., Kim J.H., Kim T.G., and Chang S.Y.. 2017. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 6:4–14. 10.7774/cevr.2017.6.1.4</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, M., El Khatib N.F., Tu S., Ren P., Xu S., Zhu Q., Mo X., Pu D., Wang X., and Altmeyer R.. 2012. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J. Clin. Virol. 53:285–289. 10.1016/j.jcv.2011.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y. 2020. Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity. Hum. Genet. 139:911–918. 10.1007/s00439-020-02127-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-020-02127-5</ArticleId><ArticleId IdType="pmc">PMC7739442</ArticleId><ArticleId IdType="pubmed">32040615</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y., and Casanova J.L.. 2015. Inborn errors underlying herpes simplex encephalitis: From TLR3 to IRF3. J. Exp. Med. 212:1342–1343. 10.1084/jem.2129insight4</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.2129insight4</ArticleId><ArticleId IdType="pmc">PMC4548049</ArticleId><ArticleId IdType="pubmed">26304982</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., et al. . 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 317:1522–1527. 10.1126/science.1139522</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1139522</ArticleId><ArticleId IdType="pubmed">17872438</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y., Herman M., Ciancanelli M.J., Pérez de Diego R., Sancho-Shimizu V., Abel L., and Casanova J.L.. 2013. TLR3 immunity to infection in mice and humans. Curr. Opin. Immunol. 25:19–33. 10.1016/j.coi.2012.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2012.11.001</ArticleId><ArticleId IdType="pmc">PMC3594520</ArticleId><ArticleId IdType="pubmed">23290562</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y., Clark N.E., Freije C.A., Pauwels E., Taggart A.J., Okada S., Mandel H., Garcia P., Ciancanelli M.J., Biran A., et al. . 2018. Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection. Cell. 172:952–965.e18. 10.1016/j.cell.2018.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.02.019</ArticleId><ArticleId IdType="pmc">PMC5886375</ArticleId><ArticleId IdType="pubmed">29474921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S.Y., Jouanguy E., Zhang Q., Abel L., Puel A., and Casanova J.L.. 2019. Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism. Curr. Opin. Immunol. 59:88–100. 10.1016/j.coi.2019.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2019.03.008</ArticleId><ArticleId IdType="pmc">PMC6774828</ArticleId><ArticleId IdType="pubmed">31121434</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. . NIAID-USUHS/TAGC COVID Immunity Group . 2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 370:eabd4570. 10.1126/science.abd4570</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer, B., Ewaleifoh O., Harschnitz O., Lee Y.S., Peneau C., McAlpine J.L., Liu B., Tchieu J., Steinbeck J.A., Lafaille F., et al. . 2018. Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection. Proc. Natl. Acad. Sci. USA. 115:E8775–E8782. 10.1073/pnas.1809853115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1809853115</ArticleId><ArticleId IdType="pmc">PMC6140487</ArticleId><ArticleId IdType="pubmed">30154162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>